What are the dangers / risks of Invokana?
Key Points
Invokana (canagliflozin) is a prescription drug used with diet and exercise to lower blood sugar in adults with type 2 diabetes. It belongs to a class of medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors. SGLT2 inhibitors lower blood sugar by blocking a certain protein and causing the kidneys to remove sugar from the body through the urine.
Warnings related to Invokana
Amputations
Invokana (canagliflozin) carries a Boxed Warning for an increased risk of lower limb amputations. A Boxed Warning is the FDA’s most stringent warning for medicines.
Two clinical studies (CANVAS, CANVAS-R trial) in patients with type 2 diabetes and heart disease (or at risk for heart disease) showed that amputations occurred about twice as often in those patients taking Invokana as in patients treated with an inactive placebo.
Your risk for amputation may be higher if you have heart disease or are at risk for heart disease, have had blocked or narrowed blood vessels, usually in the leg, nerve damage (neuropathy), diabetic foot ulcers (sores), or a history of prior amputation. Be sure to tell your doctor if you fall into any of these categories.
Contact your doctor right away if you develop any new pain or tenderness, sores or ulcers, or infections in your legs or feet. Your doctor can determine if you need to stop taking Invokana.
Learn about and engage in proper foot care if you have type 2 diabetes.
Dehydration, Low Blood Pressure
Invokana causes increased urination, which may put you at risk of dehydration (the loss of too much body water).
Dehydration may make you feel dizzy, lightheaded faint, or weak, especially when you stand up (orthostatic hypotension). This might also increase your risk for a fall.
If you take the 300 mg dose of Invokana, are 75 years of age or older, or take a loop diuretic (such as furosemide), you may be at greater risk of dehydration.
Discuss with your doctor how much fluid you should drink each day to help lower your risk for dehydration.
You could be at risk of dehydration if you:
Low blood pressure (hypotension) may occur with Invokana treatment. This can happen when you are dehydrated, too.
Tell your doctor if:
Yeast infections
Genital yeast infections are listed as a common side effect with SGLT2 inhibitors, including Invokana, and occur more frequently in women.
Symptoms of a vaginal yeast infection in women (also called vulvovaginitis or candidiasis):
In Invokana studies, the overall incidence of genital yeast infections in women was 10.6% (with the 100 mg dose), 11.6% (with the 300 mg dose) and 2.8% (inactive placebo). The number of women who had to stop treatment for this side effect was low: 0.7% of those receiving Invokana compared to 0% in the placebo group.
Symptoms of a yeast infection of the penis in men (balanitis or balanoposthitis):
Some men who are not circumcised may have swelling of the penis that makes it difficult to pull back the skin around the tip of the penis. Balanitis is most likely to occur in men who have a tight foreskin that is difficult to pull back, or who have poor hygiene. An allergy to condoms or spermicides may also worsen balanitis caused by yeast.
In men, genital yeast infections (e.g., candidal balanitis, balanoposthitis) occurred in 4.2% (with the 100 mg dose). 3.8% (with the 300 mg dose) and 0.7% (inactive placebo).
Talk to your doctor about what to do if you should get a yeast infection. This is treatable and few patients stop treatment due to this side effect. Oral prescription or over-the-counter topical antifungal treatment may be treatment options.
Ketoacidosis
Ketoacidosis is when you have increased ketones in your blood or urine, and can occur during treatment with Invokana. This is a serious condition, may need treatment in a hospital and can lead to death. Ketoacidosis can happen with Invokana even if your blood sugar is less than 250 mg/dL. You may be at greater risk of ketoacidosis if you are sick or undergoing surgery.
Stop taking Invokana and contact your doctor right away if you get any of the following symptoms:
If you get any of these symptoms during treatment with Invokana, if possible, check for ketones in your urine, even if your blood sugar is less than 250 mg/dL.
Urinary tract infections
Serious urinary tract infections (UTIs) may be a risk with Invokana treatment and other SGLT2 inhibitors. Some UTIs have resulted in hospitalization.
In clinical studies, UTIs occurred in 5.9% of patients receiving the 100 mg dose of Invokana, 4.4% of patients receiving the 300 mg dose and 3.8% of those on the inactive placebo.
Before you start treatment with Invokana, tell your doctor if you have a history of urinary tract infections or problems with urination. If you get any of the following symptoms, tell your doctor immediately:
Sudden kidney problems
Sudden (acute) kidney injury is a possible serious side effect with Invokana. Your doctor may need to temporarily discontinue your treatment.
Contact to your doctor right away if you:
If you have kidney disease, your doctor may need to reduce your dose of Invokana when you first start taking Invokana. Be sure to tell your doctor if you have a history of kidney problems.
Your doctor will follow your kidney function during treatment with Invokana.
Low blood sugar (hypoglycemia)
Low blood sugar can occur if you take Invokana with another medicine that can cause low blood sugar, such as sulfonylureas (glipizide, glimepiride) or insulin. Your medication doses may need to be adjusted.
Signs and symptoms of low blood sugar may include:
Necrotizing Fasciitis of the Perineum (Fournier’s Gangrene)
Fournier’s Gangrene is a rare but serious bacterial infection that causes damage to the tissue under your skin (necrotizing fasciitis) in the area between and around the anus and genitals (perineum). This can happen in both women and men. It can require hospitalization, multiple surgeries, and may lead to death.
Seek medical attention immediately if you have fever or if you are feeling very weak, tired or uncomfortable and you have these symptoms in the area between and around your anus and genitals:
Other side effects with Invokana may include:
Drug interactions
Invokana is also associated with some drug interactions. Some interactions can affect your dose of Invokana and you may need a dose adjustment. Be sure to tell your doctor and pharmacist about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Especially tell your doctor and pharmacist if you take:
Pregnancy and Breastfeeding
Tell your doctor if you are pregnant or plan to become pregnant while taking Invokana. Invokana may harm your unborn baby.
Invokana may also pass into your breast milk. Do not breastfeed while taking Invokana.
Talk with your doctor about the best way to control your blood sugar while you are pregnant. Also discuss the best way to feed your baby if you are taking Invokana.
Do not take Invokana:
Speak to your doctor if you think you fall into these categories.
Bottom Line
This is not all the information you need to know about Invokana (canagliflozin) for safe and effective use. Review the full Invokana information here, and speak to your health care provider if you have questions or concerns.
Related medical questions
- Can Januvia and Invokana be taken together?
- What are the dangers / risks of Invokana?
- Does Invokana cause weight loss?
- When is the best time to take Invokana?
- How long does it take for Invokana to work?
- What is Invokana used for and how does it work?
- Is it safe to take Invokana?
- How effective Is Invokana?
- Can Januvia and Invokana be taken together?
- What are the dangers / risks of Invokana?
- Does Invokana cause weight loss?
- When is the best time to take Invokana?
- How long does it take for Invokana to work?
- What is Invokana used for and how does it work?
- Is it safe to take Invokana?
- How effective Is Invokana?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions